These 8 medical isotope producing reactors provide over 90% of the world’s Mo-99 needs.
Reactor Name: National Research Universal (NRU)Location: CanadaYear Commissioned: 1957Percent of World Supply: 40%
Reactor Name: Nuclear Research Centre (BR-2)Location: BelgiumYear Commissioned: 1961Percent of World Supply: 9%
Reactor Name: High Flux Reactor (HFR)Location: NetherlandsYear Commissioned: 1961Percent of World Supply: 30%
Reactor Name: Maria Research ReactorLocation: PolandYear Commissioned: 1974Percent of World Supply: <10%
Reactor Name: LVR-15 REZ ReactorLocation: Czech RepublicYear Commissioned: 1957Percent of World Supply: <10%
Reactor Name: South African Fundamental Atomic Research Installation (SAFARI-1)Location: South AfricaYear Commissioned: 1965Percent of World Supply: 10%
Reactor Name: OPAL ReactorLocation: AustraliaYear Commissioned: 2007Percent of World Supply: 3%
Mallinckrodt, the “M” brand mark, and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2015 Mallinckrodt.
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.